All
South Beach Symposium Recap: Day 1
Catch up on coverage from the first day of South Beach Symposium.
Increasing Rates of Melanoma and What to Look For
David Goldberg, MD, JD, explores the increasing rates of melanoma in the US and how to manage melanoma subtypes at SBS 2023.
Psychosocial and Social Media Impact on Adolescent Skin Disease and Mental Health
A poster presentation from SBS 2023 analyzed the relationship between dermatology and social media.
Visiting the Sunshine State: What to do While Attending SBS
Discover fun activities to explore while attending South Beach Symposium 2023.
Aaron Farberg, MD, FAAD, Discusses Hedgehog Inhibitors at SBS
Farberg shares key pearls from his session on when to use hedgehog inhibitors at South Beach Symposium 2023.
What to Expect at the 2023 South Beach Symposium Meeting
The 2023 South Beach Symposium meeting begins today in Miami Beach, Florida.
Pointers With Portela: Men's Health
In this week’s Pointers with Dr Portela, the 208SkinDoc interviews Benjamin Bashline, DO, to discuss men's health.
Equity Indexed Life Insurance Policies and Structured Notes: Asset Classes With Principal Protection and Growth Potential
This article reviews equity-indexed life insurance policies and structured notes, instruments that offer investment protection and growth potential.
It's Unlikely that Humira Biosimilars Will Drive Down Drug Costs
As a dozen Humira Biosimilars are set to enter the market this year, it seems to be unlikely that they will drive down drug costs in the future.
The Mainstream Patient: February 7
This week's edition of the Mainstream Patient features stories about recommended razors for keratosis pilaris, dermatologist-recommended retinol serums, how to patch test skin care products, and more.
Merkel Cell Polyomavirus and Associated Merkel Cell Carcinoma
Merkel cell carcinoma is a rare but highly aggressive type of nonmelanoma skin cancer and Merkel cell polyomavirus is thought to play a major role in its etiology.
The Art of Smelling Good
In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, discusses fragrances in skin care products.
HS Treatment Response Rates Continue to Improve with Secukinumab at Week 52
Newly released safety and efficacy data on Novartis’ secukinumab for hidradenitis suppurativa is published in The Lancet.
The Weekly Roundup: January 30-February 3
ICYMI, this week we had stories about adalimumab biosimilars, an expanded Banana Boat Hair & Scalp Sunscreen recall, what's trending in skin care for January 2023, and more.
Losing a Malpractice Case May Depend on Where You Live
This month's Legal Eagle column explores what information is required during an informed consent discussion.
10 Things I Wish My Patients Knew About Atopic Dermatitis
Atopic dermatitis is not a "one-size-fits-all" condition.
The Role We Play in Addressing Racial Disparity in Dermatology
It’s important to continuously look forward to our role in serving all patients and colleagues—especially those who are underrepresented.
The Mainstream Patient: February 2
This week's edition of the Mainstream Patient features stories about sensitive skin around the eyes, health risks of sharing razors, keratin shampoos for stronger hair, and more.
Pointers With Portela: Cosmetic Treatments With Matthew Elias, DO, FAAD
In this week’s Pointers with Dr Portela, the 208SkinDoc discusses botox and other cosmetic treatments with Matthew Elias, DO, FAAD.
Celebrating Patients With Skin of Color
Explore a collection of the best skin tips for patients with skin of color.
An Overview of Granulomatous Dermatitis
Granulomatous dermatitis includes a group of reactive dermatologic disorders characterized by distinct histopathological patterns, clinical manifestations, and associated diseases.
Discover Dermatology Times: January 2023
Learn more about what in-depth topics were covered in the January 2023 issue of Dermatology Times.
What's Trending in Skin Care: January 2023
Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of January.
Pemphigus: Updated Review and Emerging Therapies
Pemphigus is defined as a group of autoimmune, blistering disorders caused by circulating autoantibodies that bind to desmogleins, proteins that are vital to epidermal intercellular adhesion.
First Adalimumab Biosimilar, Adalimumab-atto, Available in the US
Christopher Bunick, MD, PhD, and Raj Chovatiya, MD, PhD, discuss the benefits of adalimumab-atto and the future of additional biosimilars in 2023.
Spesolimab Shows Significant Prevention of GPP Flares up to 48 Weeks
Preventing generalized pustular psoriasis may be possible based on recent data.
POLL: Which Adalimumab Biosimilar Will be Available First in 2023?
Click here to answer this week's poll.
Leukemia-Related Cutaneous Findings
This review will explore various leukemia-related cutaneous findings and discuss the diagnosis and management of these conditions.
Using Lasers to Treat Medical Problems
Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, previews his laser session and live injectable demonstration at Maui Derm Hawaii 2023.
The Weekly Roundup: January 16-20
ICYMI, this week we had stories about conference coverage from Winter Clinical Hawaii, generalized pustular psoriasis management, nutritional supplements for hair loss, and more.